ANNE ANDERSON: Open Payments
NPI 1679207450 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 20 payments from 12 companies in 2025. Trend: 2023 $741 · 2024 $1,175 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $150 |
| Novo Nordisk Inc | 4 | $74 |
| ABBVIE INC. | 3 | $70 |
| Lilly USA, LLC | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Biogen, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
Products named: OMNIPOD, UBRELVY, MOUNJARO, Ozempic, GVOKE HYPOPEN, Rybelsus, LEQEMBI, Veozah.
Industry payments across FL — which companies pay providers there.
